We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
201
Tesla
TSLA
$1.24T
$1.88M 0.04%
138,405
-172,770
-56% -$2.49M
WMT icon
202
Walmart Inc
WMT
$871B
$1.88M 0.04%
78,159
+3,753
+5% +$91.1K
FDX icon
203
FedEx
FDX
$74.5B
$1.87M 0.04%
10,730
+42
+0.4% +$6.88K
LUX
204
DELISTED
Luxottica Group
LUX
$1.87M 0.04%
39,079
-535
-1% -$26K
AM
205
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
$1.86M 0.04%
+69,825
New +$1.85M
NGHCP
206
DELISTED
National General Holdings Corp Preferred Stock, Series A
NGHCP
$1.85M 0.03%
71,625
-4,000
-5% -$104K
FMX icon
207
Fomento Económico Mexicano
FMX
$43.3B
$1.84M 0.03%
19,943
-1,518
-7% -$140K
ITC
208
DELISTED
ITC HOLDINGS CORP
ITC
$1.79M 0.03%
38,621
+170
+0.4% +$7.87K
KIQ
209
DELISTED
Kelso Technologies Inc.
KIQ
$1.79M 0.03%
1,843,809
+71,645
+4% +$78.3K
XLF icon
210
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
$1.78M 0.03%
92,373
+16,169
+21% +$334K
MHNB.CL
211
DELISTED
Maiden Holdings North America
MHNB.CL
$1.76M 0.03%
68,700
-3,300
-5% -$85.6K
ROK icon
212
Rockwell Automation
ROK
$51.4B
$1.74M 0.03%
14,202
+2,300
+19% +$269K
SYK icon
213
Stryker
SYK
$127B
$1.73M 0.03%
14,827
-5,512
-27% -$642K
FAST icon
214
Fastenal
FAST
$54B
$1.72M 0.03%
164,948
-800
-0.5% -$8.51K
LLY icon
215
Eli Lilly
LLY
$1.07T
$1.7M 0.03%
21,166
+1,504
+8% +$120K
TMO icon
216
Thermo Fisher Scientific
TMO
$211B
$1.68M 0.03%
10,535
-367
-3% -$56.6K
ALXN
217
DELISTED
Alexion Pharmaceuticals
ALXN
$1.66M 0.03%
13,521
-30
-0.2% -$3.86K
IVR.PRB
218
DELISTED
INVESCO MORTGAGE CAPITAL INC. 7.75% Fixed-To-Floating Series B Cumulative Redeemable Preferred Stock
IVR.PRB
$1.65M 0.03%
64,660
+5,000
+8% +$127K
EOG icon
219
EOG Resources
EOG
$78B
$1.64M 0.03%
16,960
+50
+0.3% +$4.39K
TM icon
220
Toyota
TM
$210B
$1.61M 0.03%
13,903
-164
-1% -$18.8K
XNCR icon
221
Xencor
XNCR
$1.44B
$1.6M 0.03%
65,555
-4,000
-6% -$84.6K
IHG icon
222
InterContinental Hotels
IHG
$23B
$1.6M 0.03%
34,980
-802
-2% -$36.7K
KMPA
223
DELISTED
Kemper Corporation
KMPA
$1.59M 0.03%
59,100
-1,000
-2% -$27.6K
RHI icon
224
Robert Half
RHI
$3.61B
$1.59M 0.03%
41,950
-1,589
-4% -$60.6K
VO icon
225
Vanguard Mid-Cap ETF
VO
$106B
$1.57M 0.03%
48,504
+13,948
+40% +$447K

Similar funds

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.